Ethinyl estradiol; ferrous fumarate; norethindrone - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ethinyl estradiol; ferrous fumarate; norethindrone and what is the scope of patent protection?
Ethinyl estradiol; ferrous fumarate; norethindrone
is the generic ingredient in three branded drugs marketed by Pfizer and Parke Davis, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for ethinyl estradiol; ferrous fumarate; norethindrone
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 2 |
NDAs: | 3 |
Clinical Trials: | 1 |
DailyMed Link: | ethinyl estradiol; ferrous fumarate; norethindrone at DailyMed |
Recent Clinical Trials for ethinyl estradiol; ferrous fumarate; norethindrone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Teva Pharmaceuticals USA | Phase 1 |
See all ethinyl estradiol; ferrous fumarate; norethindrone clinical trials
Anatomical Therapeutic Chemical (ATC) Classes for ethinyl estradiol; ferrous fumarate; norethindrone
US Patents and Regulatory Information for ethinyl estradiol; ferrous fumarate; norethindrone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | NORLESTRIN FE 1/50 | ethinyl estradiol; ferrous fumarate; norethindrone acetate | TABLET;ORAL-28 | 016766-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Parke Davis | NORLESTRIN FE 2.5/50 | ethinyl estradiol; ferrous fumarate; norethindrone acetate | TABLET;ORAL-28 | 016854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | NORQUEST FE | ethinyl estradiol; ferrous fumarate; norethindrone | TABLET;ORAL-28 | 018926-001 | Jul 18, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |